SIVmac239 MVA Vaccine with and without a DNA Prime, Similar Prevention of Infection by a Repeated Dose SIVsmE660 Challenge Despite Different Immune Responses

BACKGROUND: Vaccine regimens using different agents for priming and boosting have become popular for enhancing T cell and Ab responses elicited by candidate HIV/AIDS vaccines. Here we use a simian model to evaluate immunogenicity and protective efficacy of a recombinant modified vaccinia Ankara (MVA...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Lai, Lilin, Kwa, Sue-Fen, Kozlowski, Pamela A., Montefiori, David C., Nolen, Tracy, Hudgens, Michael G., Johnson, Welkin E., Ferrari, Guido, Hirsch, Vanessa M., Felber, Barbara K., Pavlakis, George N., Earl, Patricia L., Moss, Bernard, Amara, Rama Rao, Robinson, Harriet L.
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3278564/
https://ncbi.nlm.nih.gov/pubmed/22178526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2011.12.026
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares